Drivers and strategies to combat substandard and falsified medicines in low- and middle-income countries: A systematic review of qualitative evidence
{{output}}
Substandard and falsified (SF) medicines pose a significant global public health threat, disproportionately affecting low- and middle-income countries (LMICs). While quantitative studies have documented their prevalence, a gap exists in the systematic synthesi... ...
